Breathe.me

Our goal is to predict and enable preventing the next respiratory attack. Breathe.me developed world's first ultra-low-cost Asthma & COPD monitoring & management solution, using an acoustic sensor and a mobile app for lung function testing. Our technology is patent protected. The sensor is tiny, entirely-mechanical device, that communicates wirelessly with any smartphone. The Acoustic sensor transforms airflow to a varying pitch whistle sound. The sound is recorded by the smartphone and using a proprietary algorithm, the spirometric values (such as peak flow and FEV1) are calculated. The app utilized a disease diary which records measurement results, symptoms, triggers and medication usage.

Digma Medical

We are about Restoring Glycemic Control for Type-2 Diabetes & NASH! Digma Medical is a clinical stage medical device company revolutionizing the treatment of Type-2 Diabetes and other metabolic syndrome disease such as NASH. Founded in 2013 and backed by leading venture capital firms, Digma is dedicated to the development of the DiaGoneâ„¢ to treat insulin resistance - the underlying mechanism of the disease. The DiaGoneâ„¢ is an endoscopic, disposable device, that uses state of the art laser technology to treat the duodenum without an implant. The Duodenal Glycemic Controlâ„¢ procedure is a one-time 30 minute GI procedure, in which the gastroenterologist uses the DiaGoneâ„¢ to treat the duodenum for restoring the natural ability of the body to control glucose levels, which may provide long term remission from Type-2 Diabetes, NASH, and other metabolic syndrome related disease.

EndoCross

EndoCross, founded in 2006, is devoted to the development of CTO crossing technologies. EndoCross has developed an innovative technology for enhanced guidewire pushability and true lumen crossing, by enabling distal guidewire support, centralization and advancement

CEAC Group

tremco rubber & plastic products